The evolution of cellular deficiency in GATA2 mutation

Author:

Dickinson Rachel E.1,Milne Paul1,Jardine Laura1,Zandi Sasan2,Swierczek Sabina I.3,McGovern Naomi1,Cookson Sharon1,Ferozepurwalla Zaveyna1,Langridge Alexander1,Pagan Sarah1,Gennery Andrew1,Heiskanen-Kosma Tarja4,Hämäläinen Sari4,Seppänen Mikko5,Helbert Matthew6,Tholouli Eleni7,Gambineri Eleonora8,Reykdal Sigrún9,Gottfreðsson Magnús9,Thaventhiran James E.10,Morris Emma11,Hirschfield Gideon12,Richter Alex G.13,Jolles Stephen14,Bacon Chris M.15,Hambleton Sophie1,Haniffa Muzlifah1,Bryceson Yenan16,Allen Carl17,Prchal Josef T.3,Dick John E.2,Bigley Venetia1,Collin Matthew1

Affiliation:

1. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;

2. Princess Margaret Cancer Centre, University Health Network, Toronto, and Department of Molecular Genetics, University of Toronto, Toronto, Canada;

3. Division of Hematology, School of Medicine, University of Utah, Salt Lake City, UT;

4. Department of Paediatrics, Kuopio University Hospital, Kuopio, Finland;

5. Division of Infectious Diseases, Helsinki University Central Hospital, Helsinki, Finland;

6. Department of Clinical Immunology and

7. Department of Haematology, Central Manchester University Hospitals, Manchester, United Kingdom;

8. University of Florence, Department of “NEUROFARBA”: Section of Child's Health/“Anna Meyer” Children's Hospital, Department of Haematology-Oncology, Florence, Italy;

9. Faculty of Medicine, School of Health Sciences, University of Iceland and Department of Infectious Diseases, Landspitali University Hospital, Reykjavik, Iceland;

10. Cambridge Institute for Medical Research, Cambridge, United Kingdom;

11. UCL Institute of Immunity and Transplantation, University College, London, United Kingdom;

12. Department of Hepatology and

13. Department of Clinical Immunology, University Hospital of Birmingham, Birmingham, United Kingdom;

14. Department of Immunology, University Hospital of Wales, Cardiff, United Kingdom;

15. Northern Centre for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom;

16. Centre for Infectious Medicine, Karolinska Institute, Stockholm, Sweden; and

17. Department of Pediatrics, Texas Children’s Cancer Center, Houston, TX

Abstract

Key Points Diverse patient groups with GATA2 mutation develop mononuclear cytopenia and elevated Flt3 ligand. Progressive cytopenias, rising Flt3 ligand, and terminal differentiation of lymphoid cells accompany clinical progression.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3